{
  "name": "smrnaseq-small-rna-profiling",
  "title": "sRNA-seq: microRNA & Small RNA Profiling",
  "description": "Comprehensive small RNA sequencing analysis for miRNA, piRNA, siRNA, and snoRNA quantification. Discovers novel miRNAs and analyzes post-transcriptional gene regulation. Samplesheet format: `sample,fastq_1,fastq_2`",
  "version": "1.0.0",
  "engineType": "NEXTFLOW",
  "command": "nextflow run nf-core/smrnaseq --input ${input} --outdir ${outdir} --genome ${genome} --protocol ${protocol} -r 2.4.0 ",
  "imageUrl": "https://raw.githubusercontent.com/nf-core/smrnaseq/master/docs/images/nf-core-smrnaseq_logo_light.png",
  "content": "<h2><strong>sRNA-seq: Small RNA Profiling</strong></h2><p><strong>nf-core/smrnaseq</strong> analyzes small RNA sequencing data (18-200 nt) to profile microRNAs, piRNAs, siRNAs, and other regulatory small RNAs. Essential for understanding post-transcriptional gene regulation, development, and disease.</p><h3><strong>What are Small RNAs?</strong></h3><blockquote><p><strong>Small RNAs</strong> (18-200 nucleotides) are regulatory molecules that control gene expression post-transcriptionally. They silence genes by binding complementary mRNAs or recruiting chromatin-modifying complexes.</p></blockquote><h3><strong>Small RNA Classes</strong></h3><p><strong>microRNAs (miRNAs)</strong> - 21-24 nt:</p><ul><li>Most studied class</li><li>~2,600 human miRNAs (miRBase)</li><li>Repress translation or induce mRNA decay</li><li>Regulate ~60% of protein-coding genes</li><li>Biogenesis: pri-miRNA \u2192 pre-miRNA (Drosha) \u2192 mature miRNA (Dicer)</li><li><strong>Examples</strong>: let-7 (development), miR-21 (cancer oncomiR)</li></ul><p><strong>piRNAs (PIWI-interacting RNAs)</strong> - 24-32 nt:</p><ul><li>Germline-specific (testis, ovary)</li><li>Silence transposable elements</li><li>Protect genome integrity during meiosis</li><li>26-32M human piRNAs</li><li>Bind PIWI proteins (Argonaute family)</li></ul><p><strong>siRNAs (small interfering RNAs)</strong> - 21-23 nt:</p><ul><li>Endogenous or exogenous (viral defense, RNAi experiments)</li><li>Perfect complementarity \u2192 mRNA cleavage</li><li>Antiviral immunity</li><li>Used therapeutically (Onpattro for hereditary ATTR amyloidosis)</li></ul><p><strong>snoRNAs (small nucleolar RNAs)</strong> - 60-300 nt:</p><ul><li>rRNA modification (2'-O-methylation, pseudouridylation)</li><li>Ribosome biogenesis</li><li>Some processed into miRNA-like fragments (sdRNAs)</li></ul><p><strong>tRNA fragments (tRFs)</strong> - 14-30 nt:</p><ul><li>Cleaved from mature tRNAs</li><li>Stress-induced (hypoxia, starvation)</li><li>Gene regulation, translation control</li></ul><h3><strong>Pipeline Workflow</strong></h3><ol><li><strong>Quality Control</strong>: FastQC assesses read quality</li><li><strong>Adapter Trimming</strong>: Remove 3' adapters (crucial for small RNAs)</li><li><strong>Collapse Reads</strong>: Merge identical sequences (reduce redundancy)</li><li><strong>Genome Alignment</strong>: Bowtie aligns to reference genome</li><li><strong>miRNA Quantification</strong>: Count reads mapping to known miRNAs (miRBase)</li><li><strong>Novel miRNA Discovery</strong>: miRDeep2 predicts new miRNAs</li><li><strong>Isomer Analysis</strong>: Detect isomiRs (length/sequence variants)</li><li><strong>QC Report</strong>: MultiQC aggregates all metrics</li></ol><h3><strong>Scientific Applications</strong></h3><p><strong>Cancer Biomarkers</strong>:</p><ul><li><strong>OncomiRs</strong>: miR-21, miR-155, miR-17-92 cluster (promote tumorigenesis)</li><li><strong>Tumor Suppressors</strong>: let-7, miR-34a, miR-15a/16-1 (lost in cancer)</li><li><strong>Circulating miRNAs</strong>: Liquid biopsy from blood (miR-141 in prostate cancer)</li><li><strong>Drug Resistance</strong>: miR-21 in chemoresistance</li></ul><p><strong>Development & Differentiation</strong>:</p><ul><li><strong>let-7 family</strong>: Developmental timing (larval-to-adult transition in C. elegans)</li><li><strong>miR-1, miR-133</strong>: Muscle development</li><li><strong>miR-124, miR-9</strong>: Neuronal differentiation</li><li><strong>miR-290 cluster</strong>: Embryonic stem cell identity (mouse)</li></ul><p><strong>Cardiovascular Disease</strong>:</p><ul><li><strong>miR-208, miR-499</strong>: Cardiac hypertrophy</li><li><strong>miR-126</strong>: Angiogenesis, vascular integrity</li><li><strong>miR-133</strong>: Biomarker for myocardial infarction</li></ul><p><strong>Neurodegeneration</strong>:</p><ul><li><strong>miR-29</strong>: Alzheimer's disease (regulates BACE1)</li><li><strong>miR-133b</strong>: Parkinson's disease (Pitx3 regulation)</li><li><strong>miR-206</strong>: ALS (neuromuscular junction)</li></ul><h3><strong>miRNA Biogenesis</strong></h3><blockquote><ol><li><strong>Transcription</strong>: RNA Pol II produces pri-miRNA (~1kb)</li><li><strong>Nuclear Processing</strong>: Drosha/DGCR8 cleaves to pre-miRNA (~70nt hairpin)</li><li><strong>Export</strong>: Exportin-5 transports pre-miRNA to cytoplasm</li><li><strong>Cytoplasmic Processing</strong>: Dicer cleaves to miRNA duplex (~22nt)</li><li><strong>RISC Loading</strong>: Argonaute2 (AGO2) binds guide strand</li><li><strong>Target Recognition</strong>: Seed sequence (nt 2-8) binds 3' UTR of mRNA</li></ol></blockquote><h3><strong>miRNA Target Recognition</strong></h3><p><strong>Seed Region</strong> (nucleotides 2-8):</p><ul><li>Critical for target binding</li><li>Perfect complementarity to 3' UTR</li><li>Each miRNA targets ~200-1000 mRNAs</li><li>Each mRNA regulated by multiple miRNAs</li></ul><p><strong>Mechanisms of Action</strong>:</p><ul><li><strong>Translational repression</strong>: Block ribosome (most common)</li><li><strong>mRNA deadenylation</strong>: Remove poly(A) tail \u2192 decay</li><li><strong>mRNA cleavage</strong>: If perfect complementarity (rare in mammals)</li></ul><h3><strong>IsomiRs (miRNA Isoforms)</strong></h3><p>Variants of canonical miRNA sequences:</p><ul><li><strong>5' isomiRs</strong>: Different 5' end (shifts seed sequence!)</li><li><strong>3' isomiRs</strong>: Different 3' end (most common, ~80%)</li><li><strong>Templated additions</strong>: Extra nucleotides from pri-miRNA</li><li><strong>Non-templated additions</strong>: Uridylation, adenylation (affect stability)</li></ul><p>IsomiRs can have different targets and functions than canonical miRNA</p><h3><strong>Sequencing Library Protocols</strong></h3><p><strong>Illumina TruSeq</strong>:</p><ul><li>Standard small RNA library prep</li><li>3' and 5' adapter ligation</li><li>Size selection (18-40 nt insert)</li><li>Most widely used</li></ul><p><strong>NEBNext</strong>:</p><ul><li>Less bias than TruSeq (improved ligases)</li><li>Better for low-input samples</li><li>Similar workflow</li></ul><p><strong>QIAseq miRNA</strong>:</p><ul><li>UMI-based (unique molecular identifiers)</li><li>Removes PCR duplicates accurately</li><li>Quantitative</li></ul><h3><strong>Sequencing Depth</strong></h3><table><tr><th>Goal</th><th>Reads per Sample</th><th>Notes</th></tr><tr><td><strong>miRNA Profiling</strong></td><td>5-10M reads</td><td>Detect highly/moderately expressed</td></tr><tr><td><strong>Novel miRNA Discovery</strong></td><td>20-30M reads</td><td>Find low-abundance miRNAs</td></tr><tr><td><strong>isomiR Analysis</strong></td><td>10-20M reads</td><td>Deep coverage for variants</td></tr><tr><td><strong>Biomarker Studies</strong></td><td>5-10M reads</td><td>Consistent depth across samples</td></tr></table><h3><strong>Read Length Requirements</strong></h3><ul><li><strong>Sequencing length</strong>: 50-75 bp single-end (SE)</li><li><strong>Insert size</strong>: 18-40 nt (small RNA)</li><li><strong>Adapter content</strong>: ~30-50 nt adapters on both ends</li><li><strong>Total read</strong>: Small RNA + adapters fill the read length</li></ul><h3><strong>Quality Metrics</strong></h3><ul><li><strong>Size Distribution</strong>: Peak at 21-24 nt (miRNA-enriched)</li><li><strong>Adapter Trimming</strong>: >90% reads have 3' adapter detected</li><li><strong>Mapping Rate</strong>: 60-80% to genome (miRNA regions)</li><li><strong>miRBase Mapping</strong>: 30-60% of reads (tissue-dependent)</li><li><strong>Contamination</strong>: Check for rRNA, tRNA (should be <10%)</li></ul><h3><strong>Differential Expression Analysis</strong></h3><p>Identify miRNAs with altered expression:</p><ul><li><strong>Disease vs Healthy</strong>: Biomarker discovery</li><li><strong>Treatment vs Control</strong>: Drug response</li><li><strong>Time Course</strong>: Developmental dynamics</li><li><strong>Tissue Specificity</strong>: miR-122 (liver), miR-1 (muscle), miR-124 (brain)</li></ul><p>Statistical tools: DESeq2, edgeR, limma-voom</p><h3><strong>Clinical Applications</strong></h3><p><strong>Diagnostics</strong>:</p><ul><li>Circulating miRNAs as liquid biopsy</li><li>Cancer subtyping (miRNA signatures)</li><li>Prognostic markers (survival prediction)</li></ul><p><strong>Therapeutics</strong>:</p><ul><li><strong>miRNA mimics</strong>: Restore lost tumor suppressor miRNAs</li><li><strong>AntagomiRs</strong>: Inhibit oncogenic miRNAs (anti-miR-122 for HCV)</li><li><strong>miravirsen</strong>: First miRNA therapeutic (Hepatitis C)</li></ul><h3><strong>Example miRNAs & Functions</strong></h3><table><tr><th>miRNA</th><th>Function</th><th>Dysregulation</th></tr><tr><td><strong>miR-21</strong></td><td>Anti-apoptotic, oncomiR</td><td>Upregulated in most cancers</td></tr><tr><td><strong>let-7</strong></td><td>Tumor suppressor, differentiation</td><td>Downregulated in cancer</td></tr><tr><td><strong>miR-155</strong></td><td>Immune regulation, oncomiR</td><td>Lymphoma, inflammation</td></tr><tr><td><strong>miR-122</strong></td><td>Liver function, lipid metabolism</td><td>HCV replication, liver disease</td></tr><tr><td><strong>miR-34a</strong></td><td>p53-regulated, tumor suppressor</td><td>Lost in cancer</td></tr></table><h3><strong>Input Requirements</strong></h3><p>CSV samplesheet with columns:</p><ul><li><strong>sample</strong>: Sample ID</li><li><strong>fastq_1</strong>: Path to FASTQ file (single-end)</li></ul><h3><strong>Key Outputs</strong></h3><ul><li><strong>miRNA Counts</strong>: Expression matrix (samples \u00d7 miRNAs)</li><li><strong>Novel miRNAs</strong>: Predicted by miRDeep2</li><li><strong>IsomiRs</strong>: Sequence and length variants</li><li><strong>Small RNA Classes</strong>: Breakdown (miRNA, rRNA, tRNA, snoRNA, etc.)</li><li><strong>Size Distribution</strong>: Read length histogram</li><li><strong>QC Reports</strong>: FastQC, MultiQC summaries</li></ul><blockquote><p><strong>Perfect for:</strong> miRNA biomarkers \u2022 Gene regulation \u2022 Cancer profiling \u2022 Development \u2022 Post-transcriptional control \u2022 Liquid biopsy</p></blockquote>",
  "spec": [
    {
      "type": "Stash File",
      "label": "Sample Sheet",
      "name": "input",
      "description": "CSV with small RNA-seq samples",
      "required": true,
      "restrictions": {
        "allow_files": true,
        "allow_folders": false,
        "allowed_file_types": [
          ".csv"
        ]
      }
    },
    {
      "type": "Select",
      "label": "Reference Genome",
      "name": "genome",
      "description": "Reference genome",
      "defaultValue": "GRCh38",
      "required": true,
      "options": [
        {
          "label": "Human GRCh38",
          "value": "GRCh38"
        },
        {
          "label": "Human GRCh37",
          "value": "GRCh37"
        },
        {
          "label": "Mouse GRCm39",
          "value": "GRCm39"
        }
      ]
    },
    {
      "type": "Select",
      "label": "Library Protocol",
      "name": "protocol",
      "description": "Small RNA library prep protocol",
      "defaultValue": "illumina",
      "required": true,
      "options": [
        {
          "label": "Illumina (TruSeq, NEBNext)",
          "value": "illumina"
        },
        {
          "label": "QIAseq miRNA (UMI-based)",
          "value": "qiaseq"
        },
        {
          "label": "Custom",
          "value": "custom"
        }
      ]
    },
    {
      "type": "Stash File",
      "label": "Output Directory",
      "name": "outdir",
      "description": "Output directory",
      "defaultValue": "./smrnaseq-results",
      "required": true,
      "restrictions": {
        "allow_files": false,
        "allow_folders": true
      }
    }
  ],
  "jobConfig": [
    {
      "type": "Select",
      "label": "Compute Resources",
      "name": "system_size",
      "hidden": false,
      "options": [
        {
          "label": "MEDIUM (Recommended)",
          "value": "medium",
          "mapValue": {
            "nodeSize": "MEDIUM",
            "numNodes": 1,
            "withGpu": false
          }
        },
        {
          "label": "SMALL (For few samples)",
          "value": "small",
          "mapValue": {
            "nodeSize": "SMALL",
            "numNodes": 1,
            "withGpu": false
          }
        }
      ],
      "defaultValue": "medium"
    }
  ],
  "tags": [
    {
      "id": "fb1ee42a-629a-4d99-9e7f-1da3c5f7a691",
      "name": "biology",
      "type": "field"
    },
    {
      "id": "6e4e74a4-560e-4674-95c3-60fe895b8c91",
      "name": "genomics",
      "type": "subfield"
    },
    {
      "id": "831477f4-f572-4e27-af83-037661489800",
      "name": "analysis",
      "type": "task"
    }
  ]
}